13F Holdings
中文EN

BDX BECTON DICKINSON & CO

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 10795 · Fiscal year ends 09/30

Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY5.2%
TTM net income YoY-40.6%
TTM EPS YoY-39.5%
Revenue 3-yr CAGR3.0%
Net income 3-yr CAGR-17.3%

Margins

Gross margin46.4%
Operating margin9.6%
Net margin4.5%
FCF margin13.1%
EBITDA margin21.6%

Returns

ROE3.8%
ROA1.8%
ROIC (approx.)4.2%
Asset turnover0.39x

Leverage & solvency

Liabilities / assets51.9%
Debt / equity0.69x
Current ratio0.87x
Interest coverage3.40x

Cash quality & payout

Operating cash flow / net income3.67x
Accruals ratio-4.8%
Payout ratio124.5%
Capex / revenue3.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-09-30FY20242024-09-30FY20232023-09-30FY20222022-09-30FY20212021-09-30
Income statement
Revenue$21.84B$20.18B$19.37B$18.87B$19.13B
Cost of revenue$11.91B$11.05B$11.20B$10.39B$10.50B
Gross profit$9.93B$9.12B$8.17B$8.48B$8.63B
R&D expense$1.26B$1.19B$1.24B$1.26B$1.28B
SG&A expense$5.28B$4.86B$4.72B$4.71B$4.72B
Operating income$2.58B$2.40B$2.11B$2.28B$2.25B
Interest expense$613.00M$528.00M$452.00M$398.00M$469.00M
Pretax income$1.88B$2.00B$1.66B$1.78B$1.69B
Income tax$203.00M$300.00M$132.00M$148.00M$88.00M
Net income$1.68B$1.71B$1.48B$1.78B$2.09B
EBITDA$5.04B$4.68B$4.40B$4.51B$4.48B
EPS (basic)5.835.884.975.936.92
EPS (diluted)5.825.864.945.886.85
Dividends declared per share4.163.803.643.483.32
Weighted avg. shares (diluted)288.51M291.01M288.39M287.36M292.09M
Balance sheet
Cash & equivalents$567.00M$1.79B$1.48B$1.16B$2.39B
Receivables$2.40B$3.03B$2.53B$2.19B$2.35B
Inventory$3.15B$3.84B$3.27B$3.22B$2.74B
Current assets$9.26B$10.47B$8.68B$8.14B$8.84B
PP&E, net$6.38B$6.82B$6.56B$6.01B$6.00B
Goodwill$25.96B$26.46B$24.52B$24.62B$23.89B
Intangibles$9.23B$10.87B$10.90B$12.26B$12.73B
Total assets$55.33B$57.29B$52.78B$52.93B$53.87B
Current liabilities$8.31B$8.96B$6.64B$7.81B$6.63B
Short-term debt$1.56B$2.17B$1.14B$2.18B$500.00M
Long-term debt$17.62B$17.94B$14.74B$13.89B$17.11B
Total debt$19.18B$20.11B$15.88B$16.07B$17.61B
Total liabilities$29.93B$31.40B$26.98B$27.65B$30.19B
Shareholders' equity$25.39B$25.89B$25.80B$25.28B$23.68B
Net debt$18.61B$18.32B$14.40B$14.91B$15.22B
Cash flow statement
Operating cash flow$3.43B$3.84B$2.99B$2.47B$4.13B
Capital expenditure$760.00M$725.00M$874.00M$973.00M$1.19B
Free cash flow$2.67B$3.12B$2.12B$1.50B$2.93B
Investing cash flow-$818.00M-$5.51B-$716.00M-$3.22B-$1.84B
Financing cash flow-$3.62B$2.09B-$1.96B-$736.00M-$3.31B
Depreciation & amortization$2.46B$2.29B$2.29B$2.23B$2.23B
Stock-based compensation$258.00M$247.00M$259.00M$233.00M$229.00M
Dividends paid$1.20B$1.10B$1.11B$1.08B$1.05B
Share buybacks$1.00B$500.00M$0$500.00M$1.75B

Free plan shows the latest 5 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.